{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:42:30Z","timestamp":1790822550093,"version":"4.1.0"},"reference-count":24,"publisher":"Portland Press Ltd.","issue":"5","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,18]]},"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is lethal. There is a dire need for better therapeutic targets. Cancer cells have increased demand for sugars, amino acids, and lipids and therefore up-regulate various nutrient transporters to meet this demand. In PDAC, SLC6A14 (an amino acid transporter (AAT)) is up-regulated, affecting overall patient survival. Previously we have shown using in vitro cell culture models and in vivo xenograft mouse models that pharmacological inhibition of SLC6A14 with \u03b1-methyl-l-tryptophan (\u03b1-MLT) attenuates PDAC growth. Mechanistically, blockade of SLC6A14-mediated amino acid transport with \u03b1-MLT leads to amino acid deprivation, eventually inhibiting mTORC1 signaling pathway, in tumor cells. Here, we report on the effect of Slc6a14 deletion on various parameters of PDAC in KPC mice, a model for spontaneous PDAC. Pancreatic tumors in KPC mice show evidence of Slc6a14 up-regulation. Deletion of Slc6a14 in this mouse attenuates PDAC growth, decreases the metastatic spread of the tumor, reduces ascites fluid accumulation, and improves overall survival. At the molecular level, we show lower proliferation index and reduced desmoplastic reaction following Slc6a14 deletion. Furthermore, we find that deletion of Slc6a14 does not lead to compensatory up-regulation in any of the other amino transporters. In fact, some of the AATs are actually down-regulated in response to Slc6a14 deletion, most likely related to altered mTORC1 signaling. Taken together, these results underscore the positive role SLC6A14 plays in PDAC growth and metastasis. Therefore, SLC6A14 is a viable drug target for the treatment of PDAC and also for any other cancer that overexpresses this transporter.<\/jats:p>","DOI":"10.1042\/bcj20210855","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:23:39Z","timestamp":1645784619000},"page":"719-730","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer"],"prefix":"10.1042","volume":"479","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-2537","authenticated-orcid":false,"given":"Bradley K.","family":"Schniers","sequence":"first","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S.","family":"Wachtel","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Sharma","sequence":"additional","affiliation":[{"name":"2Department of Surgical Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenija","family":"Korac","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraja","family":"Rajasekaran","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Yang","sequence":"additional","affiliation":[{"name":"3Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Sniegowski","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0799-6018","authenticated-orcid":false,"given":"Vadivel","family":"Ganapathy","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-075X","authenticated-orcid":false,"given":"Yangzom D.","family":"Bhutia","sequence":"additional","affiliation":[{"name":"1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fimmu.2018.01044","article-title":"Pancreatic ductal adenocarcinoma: a strong imbalance of good and bad immunological cops in the tumor microenvironment","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","year":"2014","journal-title":"Cancer Res."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1111\/bph.13616","article-title":"Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer","volume":"173","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.bbamcr.2015.12.017","article-title":"Glutamine transporters in mammalian cells and their functions in physiology and cancer","volume":"1863","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1042\/BJ20150751","article-title":"SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms","volume":"473","year":"2016","journal-title":"Biochem. J."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1208\/s12248-017-0164-7","article-title":"The Na+\/Cl--coupled, broad-specific, amino acid transporter SLC6A14 (ATB0,+): emerging roles in multiple diseases and therapeutic potential for treatment and diagnosis","volume":"20","year":"2017","journal-title":"AAPS J."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino acid transporters in cancer and their relevance to \u2018glutamine addiction\": novel targets for the design of a new class of anticancer drugs","volume":"75","year":"2015","journal-title":"Cancer Res."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbadis.2005.04.002","article-title":"Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans","volume":"1741","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1042\/BCJ20200099","article-title":"SLC6A14, a Na+\/Cl\u2212-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling","volume":"477","year":"2020","journal-title":"Biochem. J."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1042\/BJ20150437","article-title":"Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer","volume":"469","year":"2015","journal-title":"Biochem. J."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","article-title":"SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer","volume":"286","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2005.08.016","article-title":"Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix","volume":"100","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53r172h and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","year":"2005","journal-title":"Cancer Cell"},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","year":"2016","journal-title":"Life Sci."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/PAI.0b013e3181ad36ea","article-title":"The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver","volume":"18","year":"2010","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","article-title":"The role of stromal cancer-associated fibroblasts in pancreatic cancer","volume":"10","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"572722","DOI":"10.3389\/fonc.2020.572722","article-title":"Reprogramming of amino acid metabolism in pancreatic cancer: recent advances and therapeutic strategies","volume":"10","year":"2020","journal-title":"Front. Oncol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13105-019-00716-1","article-title":"Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1\/9","volume":"76","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","article-title":"The role of stroma in pancreatic cancer: diagnostic and therapeutic implications","volume":"9","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cam4.272","article-title":"High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas","volume":"3","year":"2014","journal-title":"Cancer Med."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-018-0947-4","article-title":"LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer","volume":"37","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-19-0959","article-title":"Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer","volume":"10","year":"2020","journal-title":"Cancer Discov."},{"key":"2023031508282038800_","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1042\/BCJ20210377","article-title":"PEPT1 is essential for the growth of pancreatic cancer cells: a viable drug target","volume":"478","year":"2021","journal-title":"Biochem. J."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/479\/5\/719\/944303\/bcj-2021-0855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/479\/5\/719\/944303\/bcj-2021-0855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T08:30:01Z","timestamp":1678869001000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/479\/5\/719\/230846\/Deletion-of-Slc6a14-reduces-cancer-growth-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3,18]]}},"URL":"https:\/\/doi.org\/10.1042\/bcj20210855","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}